Eastwood Bio-Medical Canada Inc.
EBM.VTSXVConsumer Defensive● Active
$0.95
+$0.09(+10.47%)
Market Cap$65441671
P/E Ratio—
52W High$1.1
52W Low$0.295
Eastwood Bio-Medical Canada Inc. (EBM.V) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · EBM.V · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-10 | 2024-10 | 2023-10 | 2022-10 | 2021-10 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.78M | $0.70M | $0.87M | $1.30M | $0.98M |
| Cost of Revenue | $0.28M | $0.25M | $0.43M | $0.40M | $0.52M |
| Gross Profit | $0.51M | $0.45M | $0.44M | $0.90M | $0.46M |
| Gross Margin %(computed) | 64.70% | 64.72% | 50.75% | 69.45% | 46.72% |
| Operating Expenses | |||||
| R&D Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| G&A Expenses | $0.00M | $0.52M | $0.67M | $0.92M | $0.95M |
| Total Operating Expenses | $0.86M | $0.89M | $0.95M | $1.03M | $1.05M |
| Operating Income | ($0.35M) | ($0.44M) | ($0.51M) | ($0.13M) | ($0.59M) |
| Operating Margin %(computed) | -45.35% | -62.34% | -58.30% | -9.91% | -60.23% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.01M | $0.01M | $0.03M | $0.01M | $0.00M |
| Income Before Tax | ($0.33M) | ($0.46M) | ($0.55M) | ($0.15M) | ($0.60M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.01M | $0.01M |
| Net Income | ($0.33M) | ($0.46M) | ($0.55M) | ($0.16M) | ($0.61M) |
| Net Margin %(computed) | -42.55% | -64.93% | -62.98% | -12.35% | -62.31% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.00 | $-0.01 | $-0.01 | $-0.00 | $-0.01 |
| Wtd Avg Shares | 68.89M | 68.89M | 68.89M | 68.89M | 68.89M |
| EBITDA | ($0.31M) | ($0.34M) | ($0.41M) | ($0.03M) | ($0.50M) |
| EBITDA Margin %(computed) | -39.60% | -48.72% | -47.31% | -2.49% | -50.51% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · CAD · M
Explore more Eastwood Bio-Medical Canada Inc. data
About Eastwood Bio-Medical Canada Inc. (EBM.V) Income Statement
Eastwood Bio-Medical Canada Inc. (EBM.V) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, EBM.V reported revenue of $0.00B, gross profit of $0.00B (gross margin 64.70%), and net income of ($0.00B) — a net profit margin of -42.55%.
Frequently asked questions
EBM.V · 4 questionsEastwood Bio-Medical Canada Inc. (EBM.V) reported revenue of $0.00B for 2025, up 11.4% year-over-year.
EBM.V revenueEBM.V salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08